Navigation Links
Memorial Sloan-Kettering Selects Artemis as Affiliate for India
Date:10/1/2009

Leading US cancer center enters partnership with Gurgaon based Artemis Health Institute.

Gurgaon, India (PRWEB) October 1, 2009 -- Artemis Health Institute has entered into a partnership with New York-based Memorial Sloan-Kettering Cancer Center (MSKCC), one of the world's most renowned cancer centers. The partnership will focus on three core areas -- clinical care, research and training.

Already a leading center for the diagnosis and treatment of cancer in India, the partnership with MSKCC enables Artemis Health Institute (AHI) to provide Indian patients with access to the latest protocols in cancer care, and provides MSKCC with platform to enter the Indian market. Early efforts will center on physician exchanges, joint research on clinical trials and an international cancer symposium in Gurgaon early next year.

Speaking on the tie-up, Dr Robert E Wittes, Physician-In-Chief for Memorial Hospital, said: "We have a handful of such partnerships across the world now, including Artemis in India. We will be playing an advisory role to enable Artemis to build a world class cancer clinical care, research and training facility. Together, we plan to undertake clinical research projects, and share with Artemis the latest protocols in cancer care for their patients. I believe this will go a long way in establishing a leading cancer hospital in one of the largest healthcare destinations in the world."

According to a recent World Health Organization (WHO) study, India has some of the highest cancer rates in the world, particularly for oral, throat and gall bladder cancer. Urbanization and changes in diet and lifestyle are believed to be fueling higher cancers rates in India, which have traditionally been some of the lowest in the world.

Dr. Kushagra Katariya, CEO for Artemis Health Institute, remarked that the partnership with MSKCC would have far reaching impact in the diagnosis and treatment of cancer in India. "Our collaboration with Memorial Sloan-Kettering is exciting for two reasons," stated Dr. Katariya. "It will enable us to bring to our patients the latest protocols developed at Sloan-Kettering, and help us build one of the finest cancer care facilities in this part of the world."

Artemis and Memorial Sloan-Kettering plan to co-host their first International Oncology Conference in Gurgaon sometime in the second quarter of 2010 and will provide a unique opportunity for medical professionals in India and throughout the region to learn about new developments in the diagnosis and treatment of cancer from some of the world's leading experts.

For more information, please visit http://www.artemishospital.in/

About Memorial Sloan-Kettering Cancer Center
Founded in 1884, Memorial Sloan-Kettering in New York, USA, is synonymous with cancer care and treatment across the world. The Center is a multi-faceted institution which houses a premier biomedical research institute -- the Sloan-Kettering Institute; an excellent cancer hospital in the Memorial Hospital and a PhD programme in cancer biology through the Louis V Gerstner Jr Graduate School of Biomedical Sciences.

About Artemis Health Institute
Established in late 2007, Artemis Health Institute is a multi-speciality healthcare facility based in Gurgaon, India. Cancer is one of the three super specialties along with Cardiothoracic and Orthopedics. Artemis is a wholly-owned subsidiary of PTL Enterprises, promoted by Onkar S Kanwar and listed on the Bombay Stock Exchange. Dr Kushagra Katariya is the CEO of Artemis and its Chief Cardiothoracic Surgeon.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb2969534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Childrens Memorial Research Center, Chicago Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
2. Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program
3. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
4. Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell
5. Pfizer Animal Health and NTRA Charities Team Up to Benefit the Barbaro Memorial Fund
6. Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
7. Memorial Medical First in Stanislaus County to Provide Convertible Ultrasound From ZONARE
8. Dr M Group Selects Health Robotics Technology Over RIVA for all of its I.V. Compounding Centers in South East Asia
9. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
10. Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti-Infection Treatments
11. Growing Midwestern Clinical Research Organization Selects OmniComm Systems to Provide eClinical Solutions for Phase IV Studies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Memorial Sloan-Kettering Selects Artemis as Affiliate for India
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... any gene in its endogenous context, enabling overexpression experiments and avoiding the use ... with small RNA guides is transformative for performing systematic gain-of-function studies. , ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
Breaking Biology Technology:
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... 2017 No two people are believed ... New York University Tandon School of Engineering and ... that partial similarities between prints are common enough ... phones and other electronic devices can be more ... lies in the fact that fingerprint-based authentication systems ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
Breaking Biology News(10 mins):